1 |
Bellavite P, Andrioli G, Lussignoli S, Signorini A, Orto-lani R, Conforti A. A scientific reappraisal of the 'principle of similarity'. Med Hypotheses. 1997;49(3):203-12.
DOI
|
2 |
Bellavite P, Signorini A. The emerging science of homeopathy. Berkeley (CA): North Atlantic; 2002. 424 p.
|
3 |
Teixeira MZ. 'Paradoxical strategy for treating chronic diseases': a therapeutic model used in homeopathy for more than two centuries, Homeopathy. 2005;94(4):265-6.
|
4 |
Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev. 2006;35(7):583-92.
DOI
|
5 |
Chikramane PS, Suresh AK, Bellare JR, Kane SG. Extreme homeopathic dilutions retain starting mate-rials: a nanoparticulate perspective. Homeopathy. 2010;99(4):231-42.
DOI
|
6 |
Sharma A, Purkait B. Identification of medicinally active ingredient in ultradiluted Digitalis purpurea: fluorescence spectroscopic and cyclic-voltammet-ric study. J Anal Methods Chem. 2012;2012:DOI: 10.1155/2012/109058.
DOI
|
7 |
Bellavite P, Signorini A. The emerging science of homeopathy: complexity, biodynamics and nanopharma-cology. California: North Atlantic Books; 1995. 424 p.
|
8 |
Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? a systematic review. Br Homeopath J. 2000;89(S1):S35-8.
DOI
|
9 |
Posadzki P, Alotaibi A, Ernst E. Adverse effects of homeopathy: a systematic review of published case reports and case series. Int J Clin Pract. 2012;66(12):1178-88.
DOI
|
10 |
Vickers AJ. Independent replication of pre-clinical re-search in homoeopathy: a systematic review. Forsch Komplementarmed. 2004;6(6):311-20.
DOI
|
11 |
Barve R, Chaughule R. Size-dependent in vivo/in vitro results of homoeopathic herbal extracts. J Nanostruct Chem. 2013;3(1):18.
DOI
|
12 |
Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol. 2004;4(5):504-12.
DOI
|
13 |
Rubinstein AL. Zebrafish assays for drug toxicity screening. Expert Opin Drug Metab Toxicol. 2006;2(2):231-40.
DOI
|
14 |
McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 2008;13(9-10):394-401.
DOI
|
15 |
Winter MJ, Redfern WS, Hayfield AJ, Owen SF, Valentin JP, Hutchinson TH. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods. 2008;57(3):176-87.
DOI
|
16 |
Postlethwait JH, Woods IG, Ngo-Hazelett P, Yan YL, Kelly PD, Chu F, et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res. 2000;10(12):1890-902.
DOI
|
17 |
Redfern WS, Waldron G, Winter MJ, Butler P, Holbrook N, Wallis R, et al. Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring?. J Pharmacol Toxicol Methods. 2008;58(2):110-7.
DOI
|
18 |
Parng C, Seng WL, Semino C, McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol. 2002;1(1):41-8.
DOI
|
19 |
Ali S, van Mil HGJ, Richardson MK. Large-scale assessment of the zebrafish embryo as a possible predictive model in toxicity testing. Plos one. 2011;6(6):DOI: 10.1371/journal.pone.0021076.
DOI
|
20 |
Bell IR, Muralidharan S, Schwartz GE. Nanoparti-cle characterization of traditional homeopathical-ly-manufactured silver (Argentum metallicum) medicines and placebo controls. J Nanomed Nanotechnol. 2015;6(4):DOI: 10.4172/2157-7439.1000311.
DOI
|
21 |
Westerfield M. A guide for the laboratory use of zebraf-ish danio (brachydanio) rerio. Eugene:University of Oregon Press; 2000.
|
22 |
Rajendran ES. Field emission scanning electron microscopic (FESEM) and energy dispersive spectroscopic (EDS) studies of centesimal scale potencies of the homeopathic drug Lycopodium clavatum. AJHM. 2015;108(1):9-18.
|
23 |
Test no. 236: fish embryo acute toxicity (FET) test [internet]. OECD; 2013 [Nov, 2016]. Available from: http://www.oecd-ilibrary.org/docserver/down-load/9713161e.pdf?expires=1481098481&id=id&ac-cname=guest&checksum=0EFE0447C6B022B5CA-F2AAEB18B9F3CC.
|
24 |
Hu YL, Qi W, Han F, Shao JZ, Gao JQ. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine. 2011;6:3351-9.
|
25 |
Chikramane PS, Kalita D, Suresh AK, Kane SG, Bellare JR. Why extreme dilutions reach non-zero asymptotes: a nanoparticulate hypothesis based on froth flotation. Langmuir. 2012;28(45):15864-75.
DOI
|
26 |
Upadhyay RP, Nayak C. Homeopathy emerging as na-nomedicine. International Journal of High Dilution Re-search. 2011;10(37):299-310.
|
27 |
Demangeat JL. NMR relaxation evidence for sol-ute-induced nanosized superstructures in ultramo-lecular aqueous dilutions of silica-lactose. J Mol Liq. 2010;155(2-3):71-9.
DOI
|
28 |
Konovalov A, Ryzhkina I. Highly diluted aqueous solutions: formation of nano-sized molecular assemblies (nanoassociates). Geochem Int. 2014;52(13):1207-26.
DOI
|
29 |
Linde K, Jonas WB, Melchart D, Worku F, Wagner H, Ei-tel F. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol. 1994;13(7):481-92.
DOI
|
30 |
Makri A, Goveia M, Balbus J, Parkin R. Children's susceptibility to chemicals: a review by developmental stage. J Toxicol Environ Health, Part B. 2004;7(6):417-35.
DOI
|
31 |
Fun with homeopaths and meta-analyses of homeopathy trials [internet]. Science Based Medicine; 2008. Available from: https://www.sciencebasedmedicine.org/contact-us/.
|